Cargando…

The efficacy of a leukotriene receptor antagonist in the treatment of human rectal aberrant crypt foci: a nonrandomized, open-label, controlled trial

BACKGROUND: Leukotriene receptor antagonists (LTRAs) are broadly used for the management of allergic asthma and have recently been indicated to inhibit carcinogenesis and cancer cell growth. In colorectal cancer (CRC) chemoprevention studies, the occurrence of adenoma or CRC itself is generally set...

Descripción completa

Detalles Bibliográficos
Autores principales:	Higurashi, Takuma, Arimoto, Jun, Ashikari, Keiichi, Takatsu, Tomohiro, Misawa, Noboru, Yoshihara, Tsutomu, Matsuura, Tetsuya, Fuyuki, Akiko, Ohkubo, Hidenori, Nakajima, Atsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433177/ https://www.ncbi.nlm.nih.gov/pubmed/32807113 http://dx.doi.org/10.1186/s12885-020-07266-6

Ejemplares similares

The efficacy of aspirin and metformin combination therapy in patients with rectal aberrant crypt foci: a double-blinded randomized controlled trial
por: Higurashi, Takuma, et al.
Publicado: (2020)

Difference in Defecation Desire Between Patients With and Without Chronic Constipation: A Large-Scale Internet Survey
por: Ohkubo, Hidenori, et al.
Publicado: (2020)

Prior appendectomy and cerebral infarction as potential risk factors for recurrent ischemic colitis: A retrospective observational study
por: Takatsu, Tomohiro, et al.
Publicado: (2023)

A prospective interventional trial on the effect of periodontal treatment on Fusobacterium nucleatum abundance in patients with colorectal tumours
por: Yoshihara, Tsutomu, et al.
Publicado: (2021)

Exploratory, multicenter, open-label study to evaluate the effects of linaclotide in patients with chronic constipation with an insufficient response to magnesium oxide: A study protocol
por: Yoshihara, Tsutomu, et al.
Publicado: (2022)

Efficacy of Bifidobacterium bifidum G9-1 in improving quality of life in patients with chronic constipation: a prospective intervention study
por: FUYUKI, Akiko, et al.
Publicado: (2021)

Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trial
por: Higurashi, Takuma, et al.
Publicado: (2012)

Continued Use of a Single Antiplatelet Agent Does Not Increase the Risk of Delayed Bleeding After Colorectal Endoscopic Submucosal Dissection
por: Arimoto, Jun, et al.
Publicado: (2017)

The protective effect of Bifidobacterium bifidum G9-1 against mucus degradation by Akkermansia muciniphila following small intestine injury caused by a proton pump inhibitor and aspirin
por: Yoshihara, Tsutomu, et al.
Publicado: (2020)

Investigation of the Local Recurrence Rate after Colorectal Endoscopic Mucosal Resection: Is Incomplete Polyp Resection Really a Clinically Important Problem? Analysis of the Rationale for the “Resect and Discard” Strategy
por: Arimoto, Jun, et al.
Publicado: (2019)

Aberrant crypt foci in patients with colorectal cancer.
por: Roncucci, L., et al.
Publicado: (1998)

Development of Aberrant Crypt Foci Involves a Fission Mechanism as Revealed by Isolation of Aberrant Crypts
por: Fujimitsu, Yasunobu, et al.
Publicado: (1996)

Comparison of the diagnostic performance of NBI, Laser-BLI and LED-BLI: a randomized controlled noninferiority trial
por: Higurashi, Takuma, et al.
Publicado: (2022)

Aberrant crypt foci and microadenoma as markers for colon cancer.
por: Archer, M C, et al.
Publicado: (1992)

Detection of aberrant crypt foci with image-enhanced endoscopy
por: Kagemoto, Kaizo, et al.
Publicado: (2018)

Risk factors for post-colorectal endoscopic submucosal dissection (ESD) coagulation syndrome: a multicenter, prospective, observational study
por: Arimoto, Jun, et al.
Publicado: (2018)

Relationship between the Nature of Mucus and Crypt Multiplicity in Aberrant Crypt Foci in the Rat Colon
por: Uchida, Kazumi, et al.
Publicado: (1997)

Metallothionein crypt-restricted immunopositivity indices (MTCRII) correlate with aberrant crypt foci (ACF) in mouse colon
por: Donnelly, E T, et al.
Publicado: (2005)

Aberrant Crypt Foci: The Case for Inclusion as a Biomarker for Colon Cancer
por: Wargovich, Michael J., et al.
Publicado: (2010)

Characterisation of aberrant crypt foci in carcinogen-treated rats: association with intestinal carcinogenesis.
por: Caderni, G., et al.
Publicado: (1995)

Chromoendoscopy with a Standard-Resolution Colonoscope for Evaluation of Rectal Aberrant Crypt Foci
por: Kowalczyk, Marek, et al.
Publicado: (2016)

Newly defined aberrant crypt foci as a marker for dysplasia in the rat colon
por: Ochiai, Masako, et al.
Publicado: (2014)

Occurrence of colorectal aberrant crypt foci depending on age and dietary patterns of patients
por: Kowalczyk, Marek, et al.
Publicado: (2018)

Increased Cell Proliferation of Azoxymethane‐induced Aberrant Crypt Foci of Rat Colon
por: Yamashita, Naoyuki, et al.
Publicado: (1994)

Rectal Aberrant Crypt Foci in Humans Are Not Surrogate Markers for Colorectal Cancer Risk
por: Quintanilla, Isabel, et al.
Publicado: (2019)

The Effect of Low Doses of Acetylsalicylic Acid on the Occurrence of Rectal Aberrant Crypt Foci
por: Kowalczyk, Marek, et al.
Publicado: (2022)

Diagnostic test accuracy of glutamate dehydrogenase for Clostridium difficile: Systematic review and meta-analysis
por: Arimoto, Jun, et al.
Publicado: (2016)

Distribution of lymphoid nodules, aberrant crypt foci and tumours in the colon of carcinogen-treated rats.
por: Cameron, I. L., et al.
Publicado: (1996)

Chemopreventive Efficacy of Andrographis paniculata on Azoxymethane-Induced Aberrant Colon Crypt Foci In Vivo
por: Al-Henhena, Nawal, et al.
Publicado: (2014)

Suppression of Azoxymethane‐induced Rat Colon Aberrant Crypt Foci by Dietary Protocatechuic Acid
por: Kawamori, Toshihiko, et al.
Publicado: (1994)

Inhibitory Effect of Various Breads on DMH-Induced Aberrant Crypt Foci and Colorectal Tumours in Rats
por: Qi, Guangying, et al.
Publicado: (2015)

The chemopreventive potential of Curcuma purpurascens rhizome in reducing azoxymethane-induced aberrant crypt foci in rats
por: Rouhollahi, Elham, et al.
Publicado: (2015)

Risk factors for colorectal cancer in man induce aberrant crypt foci in rats: Preliminary findings
por: Yang, Kai, et al.
Publicado: (2016)

Correction: Chemopreventive Efficacy of Andrographis paniculata on Azoxymethane-Induced Aberrant Colon Crypt Foci In Vivo
Publicado: (2015)

Dietary Conjugated Linolenic Acid Inhibits Azoxymethane‐induced Colonic Aberrant Crypt Foci in Rats
por: Kohno, Hiroyuki, et al.
Publicado: (2002)

Regressive Effects of Various Chemopreventive Agents on Azoxymethane‐induced Aberrant Crypt Foci in the Rat Colon
por: Morishita, Yukio, et al.
Publicado: (1997)

Dark Aberrant Crypt Foci with activated Wnt pathway are related to tumorigenesis in the colon of AOM-treated rat
por: Lu, Qing, et al.
Publicado: (2008)

Dark Aberrant Crypt Foci with activated Wnt pathway are related to tumorigenesis in the colon of AOM-treated rat
por: Lu, Qing, et al.
Publicado: (2008)

Magnification endoscopy to detect dysplastic aberrant crypt foci in Mexican patients with high risk for colorectal cancer
por: Trejo-Vázquez, Fabiola, et al.
Publicado: (2007)

Iminoflavones Combat 1,2-Dimethyl Hydrazine-Induced Aberrant Crypt Foci Development in Colon Cancer
por: Prasad, V. Ganga, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_es5derhbatmbsbnsl1rlfkbtah